Jacobs Levy Equity Management
CRVS icon

Jacobs Levy Equity Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Jacobs Levy Equity Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-33,968
Closed -$121K – 1036
2020
Q4 		$121K Sell
33,968
-8,000
-19% -$32.2K ﹤0.01% 988
2020
Q3 		$168K Sell
41,968
-36,666
-47% -$146K ﹤0.01% 975
2020
Q2 		$214K Buy
78,634
+58
+0.1% +$171 ﹤0.01% 940
2020
Q1 		$166K Buy
78,576
+2,580
+3% +$10.5K ﹤0.01% 911
2019
Q4 		$413K Buy
75,996
+32,979
+77% +$115K ﹤0.01% 809
2019
Q3 		$129K Sell
43,017
-16,701
-28% -$70.1K ﹤0.01% 880
2019
Q2 		$223K Buy
+59,718
New +$234K ﹤0.01% 864
2019
Q1 		– Sell
-56,174
Closed -$206K – 972
2018
Q4 		$206K Buy
56,174
+12,400
+28% +$84.5K ﹤0.01% 873
2018
Q3 		$376K Buy
+43,774
New +$438K 0.01% 830
2018
Q1 		– Sell
-14,026
Closed -$145K – 1011
2017
Q4 		$145K Buy
+14,026
New +$180K ﹤0.01% 932

Other funds holding CRVS

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return